Skip to main content

Table 3 Cardiac function and mass

From: Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis

Group

LVSP (mmHg)

dp/dt max (mmHg/s)

LVEDP (mmHg)

dp/dt min (mmHg/s)

Whole heart weight (g)

Body weight (g)

Whole heart weight/body weight (%)

Water consumption (mL/24 h)

Control

112 ± 17

5822 ± 1740

−0.08 ± 1.30

−7680 ± 1866

1.389 ± 0.185

574 ± 35

0.24 ± 0.026

33 ± 9

DCM model

88 ± 14*

3637 ± 733*

2.78 ± 2.32*

−4269 ± 1076*

1.269 ± 0.105

426 ± 56**

0.30 ± 0.020**

206 ± 50***

  1. Values given are mean ± SEM, with n = 12
  2. DCM, diabetic cardiomyopathy; LVSP, left ventricular systolic pressure; dp/dt max, the maximal uprising velocity of left ventricular pressure; LVEDP, left ventricular end diastolic pressure; dp/dt min, the maximal decreasing velocity of left ventricular pressure
  3. * P < 0.05, ** P < 0.01, *** P < 0.001 versus control group